LISANTI CAPITAL GROWTH, LLC – Supernus Pharmaceuticals, Inc. Transaction History
LISANTI CAPITAL GROWTH, LLC portfolio value:
$12.97M
portfolio value
LISANTI CAPITAL GROWTH, LLC quarter portfolio value change:
+17.05%
quarter
Supernus Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -8.03% | -33.47K shares | 921K | $33.85 | 383.18K |
Q2 2022 | share | Increase | +84.18% | 190.43K shares | 4.73M | $28.92 | 416.65K |
Q1 2022 | share | Decrease | -25.70% | -78.23K shares | -1.56M | $32.32 | 226.21K |
Q4 2021 | share | Increase | 0.00% | 304.45K shares | 8.87M | $30.03 | 304.45K |
Q3 2018 | share | Decrease | -100.00% | -60.67K shares | -3.63M | $50.35 | 0 |
Q2 2018 | share | Increase | +46.39% | 19.22K shares | 1.73M | $59.85 | 60.67K |
Q1 2018 | share | Increase | 0.00% | 41.44K shares | 1.89M | $45.8 | 41.44K |
Q4 2017 | share | Decrease | -100.00% | -25.92K shares | -1.03M | $39.85 | 0 |
Q3 2017 | share | Increase | 0.00% | 25.92K shares | 1.03M | $40 | 25.92K |
Q2 2017 | share | Increase | +322.24% | 52.38K shares | 2.44M | $43.1 | 68.63K |
Q1 2017 | share | Decrease | -62.88% | -27.53K shares | -597K | $31.3 | 16.25K |
Q4 2016 | share | Increase | +343.89% | 33.92K shares | 862K | $25.25 | 43.79K |
Q3 2016 | share | Decrease | -73.46% | -27.30K shares | -513K | $24.73 | 9.86K |
Q2 2016 | share | Increase | 0.00% | 37.17K shares | 757K | $20.37 | 37.17K |